Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Mary Lynne Hedley, a director at Eli Lilly, acquired shares of common stock through a deferral plan, while also disposing of shares held in a trust.

Summary

• Mary Lynne Hedley, a director at Eli Lilly & Co, acquired 12.73 shares of common stock on December 16, 2024, at a price of $779.
• These shares were acquired through the Lilly Directors' Deferral Plan, where stock units are granted in lieu of cash compensation and will be settled in shares after separation from service.
• Additionally, Ms. Hedley disposed of 98 shares of common stock held indirectly through a trust.
• Ms. Hedley disclaims beneficial ownership of the reported securities held in the trust, except to the extent of her pecuniary interest.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is neither particularly positive nor negative. The acquisition of shares through a deferral plan is a standard practice.

Future Outlook

The acquired stock units will be settled in shares of common stock following the reporting person's separation from service.

Industry Context

This is a routine filing related to director compensation and stock ownership, which is common practice in publicly traded companies.

Comparison to Industry Standards

• Director stock ownership and deferral plans are common across publicly traded companies, particularly in the pharmaceutical industry.
• Many companies use similar deferral plans to align director interests with long-term shareholder value.
• The specific details of these plans vary by company, but the general structure is consistent with industry norms.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with the long-term performance of the company.

Key Dates

Keywords

Eli Lilly, Director, Stock Acquisition, Deferral Plan, Beneficial Ownership, Form 4, LLY